NEW LEAF VENTURES III, L.P. – $375 MILLION LIMITED PARTNER INTERESTS – CONFIDENTIAL PRIVATE PLACEMENT MEMORANDUM APRIL, 2014 Control No. 257 NEW LEAF VENTURES III, L.P. – $375 MILLION LIMITED PARTNER INTERESTS – CONFIDENTIAL PRIVATE PLACEMENT MEMORANDUM APRIL, 2014 NEW LEAF VENT...
Results for “APT Pharmaceuticals”
Search across the indexed text of every released document.
Names that match “APT Pharmaceuticals”
86 documents found
COWEN COLLABORATIVE INSIGHTS February 25, 2019 ADDENDUM Stocks Mentioned In Important Disclosures Ticker Company Name WEED Canopy Growth Corporation GWPH GW Pharmaceuticals Plc TLRY Tilray TPB Turning Point Brands Important Disclosures and Information Relating to Cowen Wash...
…trategy to deal with : As new facts on the ground develop, phaidon debra, children meeetings, ? stock sale sale of art„ apt( large gain ), 1031 trade in , plane depreciation, boat sale. construction, brad will oversee brokerage and HOUSE OVERSIGHT 023221 investment, ?? pe. real e...
…ets Member Coro NewYork NY Corooratlon PresidenUDirector 140 Seven Sorinas LLC NewYork NY LLC President 142 Shore Haven APt#1 ,Inc New York, NY Corooralion DireclorNice President 143 Shore Haven Shooolng Center LLC NewYork NY LLC Member 144 SLC Turnberrv Limited rTrumo Turnberrvl...
Table 19: S&P 500 companies with high (>35%) median 5-year effective tax rates and low (<10%) foreign sales Foreign Sales 5-Year Median Effective Tax Ticker Company Name Sector Industry % Rate % FE FirstEnergy Corp. Utilities Electric Utilities 0% 35.3 ZION Zions Bancorporation...
Sprout Capital IX, L.P. (Healthcare Technology Portfolio) $ amounts in millions, as of March 31, 2014 Please refer to Endnotes 1,],K,L,M and N in this Appendix. Gross Multiple Total Value Realized Unrealized Value Value Total Cost Vintage Company Sector Year Portion) Gross...
…ReTargeter. *Amy Salzhauer *12% CEO, Ignition. *Cami Samuels*ig% General Partner, Versant Ventures. Boards: Achaogen, APT Pharmaceuticals, Kythera Biopharmaceuticals, Semprae Laboratories. *Ken Sawyer*-- CEO, Saints Ventures (manages over $1 billion in capital). Selected to Fo...
…. Board: ReTargeter. Amy Salzhauer — CEO, Ignition. Cami Samuels — General Partner, Versant Ventures. Boards: Achaogen, APT Pharmaceuticals, Kythera Biopharmaceuticals, Semprae Laboratories. Ken Sawyer -- CEO, Saints Ventures (manages over $1 billion in capital). Selected to Forb...
…Board: ReTargeter. Amy Salzhauer - CEO, Ignition. Cami Samuels - General Partner, Versant Ventures. Boards: Achaogen, APT Pharmaceuticals, Kythera Biopharmaceuticals, Semprae Laboratories. Ken Sawyer -- CEO, Saints Ventures (manages over $1 billion in capital). Selected to For...
…oard: ReTargeter. *Amy Salzhauer *— CEO, Ignition. *Cami Samuels*— General Partner, Versant Ventures. Boards: Achaogen, APT Pharmaceuticals, Kythera HOUSE OVERSIGHT 017587 Biopharmaceuticals, Semprae Laboratories. *Ken Sawyer*-- CEO, Saints Ventures (manages over $1 billion in ca...
“pL! Villaggia WSS Oclan Dr. apt S| Greta, iam Aventura timo 1s back in PB 114-05 46 Gretchen fe éFeiends apt?) “peenrny sth) Pinto Bord Tam (Port St) Courtiey WW. Adventure Lumpusing Seniee ulalos PO BOX Bo-o1Ue Fed ID 65-0376225 Aduertron , FL 32280 trip blroles 420 Am M...
…r pressure from his peers Wiener brought out a revised and milder edition in 1954, from which the original concluding chapter, “Voices of Rigidity,” is conspicuously absent. Science historian George Dyson points out that in this long-forgotten first edition, Wiener predicted the...
and because cannabis may be an alternative to pharmaceuticals currently used
a $317 million financing was completed by GW Pharmaceuticals (Nasdaq: GWPH)
molecular immunology at The Pasteur Institute and earned an M.D. and Ph.D. from the University of Paris, and an M.B.A. from Columbia University. Jeani Delagardelle, (57), Managing Director, helped found New Leaf in 2005. She joined Sprout in 2000. At New Leaf, Jeani leads the Me...